MING ZHOU to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications MING ZHOU has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.033
-
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results. J Clin Oncol. 2023 10 20; 41(30):4756-4767.
Score: 0.033
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.